CD,

If BETonMACE returns a 30% RRR what is your guesstimate that Hepalink wpuld pay for US rights,..? Do you think RVX would get a royalty from the US sales or would it be a straight sale.

Thanks

To answer your initial question. My opinion is that I think DM/RVX will sell off Apabetalone after (if and when) Phase III approval. I think it will be very much like a Zenith Capital deal.  Nobody is certain when full results will be announced.  If no full results by April 2019, I think that Hepalink will exercise and RVX gets infused with cash to keep all the other trials going.  Hepalink is in deep and I'm afraid to say is not in a position to back away. the finish line is too close for anyone to not see the final results.